Serial Tuberculin Skin Tests Improve the Detection of Latent Tuberculosis Infection in Patients With Inflammatory Bowel Disease-Reference-Cited by-同舟云学术

Serial Tuberculin Skin Tests Improve the Detection of Latent Tuberculosis Infection in Patients With Inflammatory Bowel Disease

Published:2018-07-21 Issue:11 Volume:12 Page:1270-1279
ISSN:1873-9946
Container-title:Journal of Crohn's and Colitis
language:en
Short-container-title:

Author:

Taxonera Carlos¹,Ponferrada Ángel²,Riestra Sabino³,Bermejo Fernando⁴,Saro Cristina⁵,Martín-Arranz María Dolores⁶,Cabriada José Luis⁷,Barreiro-de Acosta Manuel⁸,de Castro María Luisa⁹,López-Serrano Pilar¹⁰,Barrio Jesús¹¹,Suarez Cristina¹²,Iglesias Eva¹³,Argüelles-Arias Federico¹⁴,Ferrer Isabel¹⁵,Marín-Jiménez Ignacio¹⁶,Hernández-Camba Alejandro¹⁷,Bastida Guillermo¹⁸,Van Domselaar Manuel¹⁹,Martínez-Montiel Pilar²⁰,Olivares David¹,Rivero Montserrat²¹,Fernandez-Salazar Luis²²,Nantes Óscar²³,Merino Olga²⁴,Alba Cristina¹,Gisbert Javier P²⁵,del Mar Martín-Rodriguez María,Botella Belén,Carpio Daniel,Ceballos Daniel,Verdejo Cristina,Morales Ignacio,Legido Jesús,Peñate Mónica,Chaparro María,Algaba Alicia,de Francisco Ruth,

Affiliation:

1. Department of Gastroenterology, Hospital Clínico San Carlos and Instituto de Investigación del Hospital Clínico San Carlos [IdISSC], Madrid, Spain

2. Department of Gastroenterology, Hospital Infanta Leonor, Madrid, Spain

3. Department of Gastroenterology, Hospital Universitario Central de Asturias and Instituto de Investigación Biosanitaria del Principado de Asturias [ISPA], Oviedo, Spain

4. Department of Gastroenterology, Hospital Universitario de Fuenlabrada, Madrid, Spain

5. Department of Gastroenterology, Hospital de Cabueñes, Gijón, Spain

6. Department of Gastroenterology, Hospital La Paz, Madrid, Spain

7. Department of Gastroenterology, Hospital de Galdakao, Galdakao, Spain

8. Department of Gastroenterology, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain

9. Department of Gastroenterology, Complejo Hospitalario Universitario de Vigo, Vigo, Spain

10. Department of Gastroenterology, Hospital Universitario Fundación Alcorcón, Madrid, Spain

11. Department of Gastroenterology, Hospital Universitario Río Hortega, Valladolid, Spain

12. Department of Gastroenterology, Hospital Puerta de Hierro, Madrid, Spain

13. Department of Gastroenterology, Hospital Reina Sofía, Córdoba, Spain

14. Department of Gastroenterology, Hospitales Virgen Macarena-Rocío, Sevilla, Spain

15. Department of Gastroenterology, Hospital de Manises, Manises, Spain

16. Department of Gastroenterology, Hospital Gregorio Marañón and Instituto de Investigación Sanitaria Gregorio Marañón [IiSGM], Madrid, Spain

17. Department of Gastroenterology, Hospital Universitario de Canarias, La Laguna, Spain

18. Department of Gastroenterology, Hospital La Fe, Valencia, Spain

19. Department of Gastroenterology, Hospital Universitario de Torrejón, Madrid, Spain

20. Department of Gastroenterology, Hospital Universitario 12 de Octubre, Madrid, Spain

21. Department of Gastroenterology, Hospital Universitario Marqués de Valdecilla, Santander, Spain

22. Department of Gastroenterology, Hospital Clínico de Valladolid, Valladolid, Spain

23. Department of Gastroenterology, Complejo Hospitalario de Navarra and Instituto de Investigación Sanitaria de Navarra [IdiSNA], Pamplona, Spain

24. Department of Gastroenterology, Hospital Universitario Cruces, Bilbao, Spain

25. Department of Gastroenterology, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa [IIS-IP] and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas [CIBEREHD], Madrid, Spain

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,General Medicine

Link

http://academic.oup.com/ecco-jcc/article-pdf/12/11/1270/26571601/jjy104.pdf

Reference35 articles.

1. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent;Keane;N Engl J Med,2001

2. Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report;Gómez-Reino;Arthritis Rheum,2003

3. Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy;Wolfe;Arthritis Rheum,2004

4. BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-alpha treatment;British Thoracic Society Standards of Care Committee;Thorax,2005

5. negative screening does not rule out the risk of tuberculosis in patients with inflammatory bowel disease undergoing anti-TNF treatment: a descriptive study on the GETAID cohort;Abitbol;J Crohns Colitis,2016

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consenso para la gestión de riesgo en la prescripción de terapias biológicas o de antirreumáticos sintéticos con blanco dirigido: Asociación Colombiana de Reumatología 2023;Revista Colombiana de Reumatología;2024-04

2. Regional risk of tuberculosis and viral hepatitis with tumor necrosis factor-alpha inhibitor treatment: A systematic review;Frontiers in Pharmacology;2023-01-20

3. Management and monitoring of pediatric inflammatory bowel disease in the Asia‐Pacific region: A position paper by the Asian Pan‐Pacific Society for Pediatric Gastroenterology, Hepatology, and Nutrition (APPSPGHAN) PIBD Working Group: Surgical management, disease monitoring, and special considerations;Journal of Gastroenterology and Hepatology;2023-01-13

4. Active tuberculosis in inflammatory bowel disease patients: a case–control study;Therapeutic Advances in Gastroenterology;2023-01

5. Core indicators of an evaluation and guidance system for quality of care in inflammatory bowel disease centers: A critical review;eClinicalMedicine;2022-04